News Summary: FDA clears weight-loss tablet Belviq

<p>THE NEWS: <span>Arena Pharmaceutical</span>‘s anti-obesity drug Belviq perceived <span>regulatory approval</span> Wednesday, a initial such drug to get <span>FDA clearance</span> for long-term <span>weight loss</span> in 13 years.</p>
<p>THE DRUG: Belviq is authorized for adults who are portly or are overweight with during slightest one <span>medical complication</span>, such as <span>diabetes</span> or high cholesterol. It should be used in multiple with a healthy diet and exercise.</p>
<p>THE RESULTS: On normal patients mislaid 3 to 3.7 percent of their starting physique weight over a year. About 47 percent of patients but diabetes mislaid during slightest 5 percent of their weight or more.</p>
<p><img src="http://imageads.googleadservices.com/pagead/ads?format=468x30_aff_img&client=&channel=&output=png&cuid=3103&url=%20http%3A%2F%2Fmedicalinfo.i...